RT Journal Article
SR Electronic
T1 WITHDRAWN: Prevalence of <em>katG</em> and <em>inhA</em> mutations in genes associated with isoniazid resistance in <em>Mycobacterium tuberculosis</em> clinical isolates in Cameroon
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.19.24307581
DO 10.1101/2024.05.19.24307581
A1 Nono, Vanessa Ninkeh
A1 Nantia, Edouard Akono
A1 Mutshembele, Awelani Miranda
A1 Teagho, Sorelle Nguimfack
A1 Simo, Yannick Willy Kamdem
A1 Takong, Brenda Shile
A1 Djieugoue, Yvonne Josiane
A1 Assolo, Yannick Patrick
A1 Ongboulal, Suzanne Magloire
A1 Awungafac, Stanley Nkemnji
A1 Eyangoh, Sara
A1 Makhado, Ndivuhu Agnes
A1 Mensah, Eric
A1 Donfack, Valerie Flore Donkeng
YR 2024
UL http://medrxiv.org/content/early/2024/07/24/2024.05.19.24307581.abstract
AB This manuscript has been withdrawn by the authors as it was submitted and made public without the full consent of all the authors. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Centre Regional Ethics Committee for Human Research of the Ministry of Public Health, Cameroon gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes